Oscar Gallego - Publications

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 18, 2025

Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study.

Journal: NPJ precision oncology

Published: June 16, 2025

Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.

Journal: BMC cancer

Published: June 16, 2025

SEOM-AEEMT consensus on occupational cancer and cancer-associated disability.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 06, 2025

Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy.

Journal: Oral oncology

Published: May 25, 2025

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Journal: Journal of neuro-oncology

Published: March 13, 2024

Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Journal: Brazilian journal of otorhinolaryngology

Published: February 21, 2024

Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

Journal: Journal of neuro-oncology

Published: January 30, 2024

A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

Journal: Journal of neuro-oncology

Published: October 11, 2023

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.

Journal: Cells

Published: January 22, 2023

In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.

Journal: Scientific reports

Published: June 01, 2022

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 16, 2020